IROs Help Determine Medical Necessity Of Growth Hormone Therapy
Today the human growth hormone (HGH) industry approaches $2 billion a year. It claims benefits for enhancing athletic performance, anti-aging and stimulating growth. Unfortunately, many of these remain unproven says NAIRO, trade association of independent review organizations (IROs) whose members see daily requests from health plans asking about the medical necessity of growth hormone therapies.
More: continued here
Filed under: Endocrinology on April 15th, 2009
You must be logged in to post a comment.